The discovery of orally available thrombin inhibitors: Optimisation of the P1 pharmacophore

被引:8
作者
Ambler, J [1 ]
Bentley, D [1 ]
Brown, L [1 ]
Dunnet, K [1 ]
Farr, D [1 ]
Janus, D [1 ]
Le Grand, D [1 ]
Menear, K [1 ]
Mercer, M [1 ]
Talbot, M [1 ]
Tweed, M [1 ]
Wathey, B [1 ]
机构
[1] Novartis Horsham Res Ctr, Horsham RH12 4AB, W Sussex, England
关键词
D O I
10.1016/S0960-894X(99)00138-9
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Thrombin inhibitors have been designed with the replacement of the strongly basic guanidine P1 pharmocophore with a group that exploits the lipophilicty of the S1 pocket. The approach has lead to the discovery of potent thrombin inhibitors demonstrating good intra-duodenal absorption. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1103 / 1108
页数:6
相关论文
共 8 条
[1]  
Ammar HO, 1997, PHARMAZIE, V52, P627
[2]  
BODE W, 1992, PROTEIN SCI, V1, P426
[3]  
BRIGITTE K, 1998, DRUGS FUTURE, V23, P423
[4]  
Fareed Jawed, 1992, P63
[5]   HEPARINS [J].
HIRSH, J .
FIBRINOLYSIS, 1995, 9 :66-68
[6]   THROMBIN INHIBITORS .3. CARBOXYL-CONTAINING AMIDE DERIVATIVES OF N-ALPHA-SUBSTITUTED L-ARGININE [J].
KIKUMOTO, R ;
TAMAO, Y ;
OHKUBO, K ;
TEZUKA, T ;
TONOMURA, S ;
OKAMOTO, S ;
HIJIKATA, A .
JOURNAL OF MEDICINAL CHEMISTRY, 1980, 23 (12) :1293-1299
[7]   Design and synthesis of a series of potent and orally bioavailable noncovalent thrombin inhibitors that utilize nonbasic groups in the P1 position [J].
Tucker, TJ ;
Brady, SF ;
Lumma, WC ;
Lewis, SD ;
Gardell, SJ ;
Naylor-Olsen, AM ;
Yan, YW ;
Sisko, JT ;
Stauffer, KJ ;
Lucas, BJ ;
Lynch, JJ ;
Cook, JJ ;
Stranieri, MT ;
Holahan, MA ;
Lyle, EA ;
Baskin, EP ;
Chen, IW ;
Dancheck, KB ;
Krueger, JA ;
Cooper, CM ;
Vacca, JP .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (17) :3210-3219
[8]   Small-molecule direct thrombin inhibitors [J].
Wiley, MR ;
Fisher, MJ .
EXPERT OPINION ON THERAPEUTIC PATENTS, 1997, 7 (11) :1265-1282